| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Breast Imaging |
1 From the Institute of Diagnostic Radiology (S.C.A.M., T.M.K., B.M., R.A.K.H.), Department of Obstetrics and Gynecology (D.F.), and Department of Pathology (R.C.), University Hospital Zurich, Switzerland; Department of Biostatistics, University of Zurich, Switzerland (B.S.); and Guerbet, Zurich, Switzerland (J.M.F.). From the 2001 RSNA scientific assembly. Received September 28, 2001; revision requested December 10; revision received January 7, 2002; accepted February 26. Supported in part by a grant from the Legat Frau Henriette Rossiez-Treichler, Zurich, Switzerland. Address correspondence to R.A.K.H., Institute of Diagnostic Radiology, Cantonal Hospital, CH-5404 Baden, Switzerland (e-mail: rahel.kubik@ksb.ch).
PURPOSE: To evaluate magnetic resonance (MR) imaging with ultrasmall superparamagnetic iron oxide (USPIO) enhancement for preoperative axillary lymph node staging in patients with breast cancer by using histopathologic findings as the standard of reference.
MATERIALS AND METHODS: MR imaging was performed with a 1.5-T system within 24–36 hours after the start of intravenous slow-drip infusion of USPIO in 20 patients with breast cancer who were scheduled for surgery, followed by gadolinium-enhanced MR imaging. Lymph nodes were staged prospectively by using newly established criteria, and results were correlated with histologic findings.
RESULTS: In two patients, preoperative findings led to a change in therapeutic approach, and neoadjuvant chemotherapy was given; both patients were excluded from statistical analysis. Results of axillary staging with USPIO-enhanced MR imaging were true-positive in nine, true-negative in seven, false-positive in zero, and false-negative in two of 18 patients (sensitivity, 82%; specificity, 100%; positive predictive value, 100%; second reader, 
= 1.0). Four hundred five lymph nodes were detected with MR imaging. For first and second readers, respectively, lymph node–based sensitivity was 83% and 73% and specificity was 96% and 97% ( = 0.68). USPIO as the intravascular contrast agent could not replace gadolinium for assessment of the primary tumor; however, no clinically relevant interaction was seen. Thus, an integrated imaging approach was feasible in all patients.
CONCLUSION: USPIO-enhanced MR imaging has the potential to become an adjunct to conventional MR imaging of the breast for preoperative assessment of axillary lymph nodes in patients with breast cancer.
© RSNA, 2002
Index terms: Breast neoplasms, MR 00.121411, 00.121412, 07.121411, 07.121412 • Breast neoplasms, metastases, 07.33 • Contrast media, comparative studies, 00.12143 • Iron • Lymphatic system, MR, 07.12143 • Lymphatic system, neoplasms, 07.33 • Magnetic resonance (MR), contrast enhancement, 07.12143
This article has been cited by other articles:
|
|
 |
|
  H. Abe, R. A. Schmidt, K. Kulkarni, C. A. Sennett, J. S. Mueller, and G. M. Newstead Axillary Lymph Nodes Suspicious for Breast Cancer Metastasis: Sampling with US-guided 14-Gauge Core-Needle Biopsy--Clinical Experience in 100 Patients Radiology, January 1, 2009; 250(1): 41 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. Pandharipande, M. G. Harisinghani, E. M. Ozanne, M. C. Specht, C. Hur, J. M. Lee, and G. S. Gazelle Staging MR Lymphangiography of the Axilla for Early Breast Cancer: Cost-Effectiveness Analysis Am. J. Roentgenol., November 1, 2008; 191(5): 1308 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. A. Margolis, J. M. Hoffman, R. J. Herfkens, R. B. Jeffrey, A. Quon, and S. S. Gambhir Molecular Imaging Techniques in Body Imaging Radiology, November 1, 2007; 245(2): 333 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Kuhl Current Status of Breast MR Imaging * Part 2. Clinical Applications Radiology, September 1, 2007; 244(3): 672 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saksena, M. Harisinghani, P. Hahn, J. Kim, A. Saokar, B. King, and R. Weissleder Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers. Am. J. Roentgenol., December 1, 2006; 187(6): W582 - W588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Choi, M. H. Han, W. K. Moon, K. R. Son, J.-K. Won, J.-H. Kim, B. J. Kwon, D. G. Na, H.-J. Weinmann, and K.-H. Chang Cervical Lymph Node Metastases: MR Imaging of Gadofluorine M and Monocrystalline Iron Oxide Nanoparticle-47 in a Rabbit Model of Head and Neck Cancer Radiology, December 1, 2006; 241(3): 753 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Memarsadeghi, C. C. Riedl, A. Kaneider, A. Galid, M. Rudas, W. Matzek, and T. H. Helbich Axillary Lymph Node Metastases in Patients with Breast Carcinomas: Assessment with Nonenhanced versus USPIO-enhanced MR Imaging. Radiology, November 1, 2006; 241(2): 367 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Lopez and S Chakravarti Imaging of cervical cancer Imaging, August 1, 2006; 18(1): 10 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer Arch Surg, August 1, 2006; 141(8): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Atri New Technologies and Directed Agents for Applications of Cancer Imaging J. Clin. Oncol., July 10, 2006; 24(20): 3299 - 3308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Cox, J. M. Cox, L. B. White, N. G. Stowell, J. D. Clark, N. Allred, M. Meyers, E. Dupont, B. Furman, and S. Minton Sentinel Node Biopsy Before Neoadjuvant Chemotherapy for Determining Axillary Status and Treatment Prognosis in Locally Advanced Breast Cancer Ann. Surg. Oncol., April 1, 2006; 13(4): 483 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Harisinghani, M. A. Saksena, P. F. Hahn, B. King, J. Kim, M. T. Torabi, and R. Weissleder Ferumoxtran-10-Enhanced MR Lymphangiography: Does Contrast-Enhanced Imaging Alone Suffice for Accurate Lymph Node Characterization? Am. J. Roentgenol., January 1, 2006; 186(1): 144 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Taschner, S. G. Wetzel, M. Tolnay, J. Froehlich, A. Merlo, and E. W. Radue Characteristics of Ultrasmall Superparamagnetic Iron Oxides in Patients with Brain Tumors Am. J. Roentgenol., December 1, 2005; 185(6): 1477 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Lutz, D. Weishaupt, E. Persohn, K. Goepfert, J. Froehlich, B. Sasse, J. Gottschalk, B. Marincek, and A. H. Kaim Imaging of Macrophages in Soft-Tissue Infection in Rats: Relationship between Ultrasmall Superparamagnetic Iron Oxide Dose and MR Signal Characteristics Radiology, March 1, 2005; 234(3): 765 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. L. L. G. Deserno, M. G. Harisinghani, M. Taupitz, G. J. Jager, J. A. Witjes, P. F. Mulders, C. A. Hulsbergen van de Kaa, D. Kaufmann, and J. O. Barentsz Urinary Bladder Cancer: Preoperative Nodal Staging with Ferumoxtran-10-enhanced MR Imaging Radiology, November 1, 2004; 233(2): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Mamounas Tailoring Loco-Regional Therapy with Neoadjuvant Chemotherapy: Another Step in the Right Direction Ann. Surg. Oncol., October 1, 2004; 11(10): 888 - 891. [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Harisinghani, W. T. Dixon, M. A. Saksena, E. Brachtel, D. J. Blezek, P. J. Dhawale, M. Torabi, and P. F. Hahn MR Lymphangiography: Imaging Strategies to Optimize the Imaging of Lymph Nodes with Ferumoxtran-10 RadioGraphics, May 1, 2004; 24(3): 867 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Luciani, T. H. Dao, M. Lapeyre, M. Schwarzinger, C. Debaecque, L. Lantieri, G. Revelon, M. Bouanane, H. Kobeiter, and A. Rahmouni Simultaneous Bilateral Breast and High-Resolution Axillary MRI of Patients with Breast Cancer: Preliminary Results Am. J. Roentgenol., April 1, 2004; 182(4): 1059 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Harisinghani, J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, and R. Weissleder Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer N. Engl. J. Med., June 19, 2003; 348(25): 2491 - 2499. [Abstract] [Full Text] [PDF]
|
|
